Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease"
- PMID: 20549561
- PMCID: PMC3018273
- DOI: 10.1245/s10434-010-1146-5
Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease"
Comment on
-
Chromogranin A--biological function and clinical utility in neuro endocrine tumor disease.Ann Surg Oncol. 2010 Sep;17(9):2427-43. doi: 10.1245/s10434-010-1006-3. Epub 2010 Mar 9. Ann Surg Oncol. 2010. PMID: 20217257 Review.
References
-
- Modlin IM, Gustafsson BI, Moss SF, et al. Chromogranin A—biological function and clinical utility in neuroendocrine tumor disease. Ann Surg Oncol. doi:1245/s10434-010-1006-3. - PubMed
-
- Woltering EA, Hilton RS, Zolfoghary ChM, et al. Validation of serum versus plasma measurements of chromogranin A levels in patients with carcinoid tumors. Lack of correlation between absolute chromogranin A levels and symptoms frequency. Pancreas. 2006;33:250–254. doi: 10.1097/01.mpa.0000235302.73615.d4. - DOI - PubMed
-
- Glinicki P, Kapuścińska R, Jeske W. The difference in chromogranin A (CgA) concentration measured in plasma and serum. Endokrynol Pol. 2010;61(2):241. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
